Skip to content

OAB and the Microbiome

Trends in the Microbiome Profiles of Women With Urgency and Frequency Syndrome, With or Without Pelvic Pain?

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04831801
Enrollment
39
Registered
2021-04-05
Start date
2021-06-30
Completion date
2023-11-20
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder, Urgency-frequency Syndrome

Brief summary

To determine differences in the urinary microbiomes, identified by polymerase change reaction (PCR) (UTIP™), of female patients with urgency and frequency syndrome with or without pelvic pain (Group A) compared to female controls without symptoms of lower urinary tract symptoms (LUTS) (Group B).

Interventions

None listed

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 y/o-90 y/o * Able to consent * Group A only: Urgency and Frequency Syndrome or OAB only. UDI-6 answer of moderately to quite a bit on questions 1 or 2. * Group B only: Urinary Distress Inventory 6 (UDI-6) answer not at all or somewhat for questions 1 or 2.

Exclusion criteria

* Pregnant * Pelvic radiation * Urinary retention (\>200 ml) * Renal calculi * Recurrent urinary tract infection (UTI) (2 in 6 months), or * Current UTI * Immunosuppressed or radiation history * Neurologic disorder

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients with Lactobacillus in samples.Day 1Evaluation of urine and perineal samples by PCR.
Proportion of patients negative for repeat sequencing.Day 1Evaluation of urine and perineal samples by PCR.
Proportion of patients with change in UDI-6 scoreUp to 4 weeksUDI 6 question 1 and 2 has a total score from 0-6 with a high score indicating more distress. Proportion of patients with a decrease in score from baseline will be reported for this outcome.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026